2001/204/EC: Council Decision of 8 March 2001 supplementing Directive 90/219/EEC as regards the criteria for establishing the safety, for human health and the environment, of types of genetically modified micro-organisms (Text with EEA relevance)
Date: 2001-03-08
Institutions: Council of the European Union
Subjects: environmental protection, genetically modified organism, impact study, microorganism, product safety, public health

L 73/32

EN

Official Journal of the European Communities

15.3.2001

COUNCIL DECISION

of 8 March 2001

supplementing Directive 90/219/EEC as regards the criteria for establishing the safety, for human
health and the environment, of types of genetically modified micro-organisms

(Text with EEA relevance)

(2001/204/EC)

THE COUNCIL OF THE EUROPEAN UNION,

HAS ADOPTED THIS DECISION:

Having regard to the Treaty establishing the European
Community,

Having regard to Council Directive 90/219/EEC of 23 April
1990 on the contained use of genetically modified micro-
organisms (1), and in particular Article 20a thereof,

Having regard to the proposal from the Commission,

Whereas:

(1)

(2)

According to Article 3 of Directive 90/219/EEC, that
Directive is not to apply to contained uses involving
only types of genetically modified micro-organisms
(GMMs) meeting the criteria listed in Part B of Annex II
thereto, which establish their safety for human health
and the environment.

By virtue of Article 20a of Directive 90/219/EEC, the
criteria establishing the safety, for human health and the
environment, of types of genetically modified micro-
organisms to be included in Part C of Annex II to that
Directive should be adopted. In order to facilitate the
application of those criteria, it should be made possible
for the Commission to adopt detailed guidance notes, in
accordance with the procedure referred to in Article 21
of that Directive.

(3)

Directive 90/219/EEC should be supplemented accord-
ingly,

Article 1

Part B of Annex II to Directive 90/219/EEC shall be replaced by
the text in the Annex to this Decision.

Article 2

This Decision shall be published in the Official Journal of the
European Communities.

Article 3

This Decision shall apply from the day of its publication in the
Official Journal of the European Communities.

Article 4

This Decision is addressed to the Member States.

Done at Brussels, 8 March 2001.

For the Council

The President

K. LARSSON

(1) OJ L 117, 8.5.1990, p. 1. Directive as last amended by Directive

98/81/EC (OJ L 330, 5.12.1998, p. 13).

15.3.2001

EN

Official Journal of the European Communities

L 73/33

ANNEX

‘PART B

Criteria establishing the safety of GMMs for human health and the environment

This Annex describes in general terms the criteria to be met when establishing the safety of types of GMMs for human
health and the environment and their suitability for inclusion in Part C. It will be supplemented by guidance notes for the
easy application of such criteria, such notes being developed and, if necessary, amended by the Commission in accordance
with the procedure referred to in Article 21.

1.

INTRODUCTION

Types of genetically modified micro-organisms (GMMs) listed in Part C in accordance with the procedure referred
to in Article 21 are excluded from the scope of this Directive. GMMs will be added to the list on a case-by-case
basis and exclusion will relate only to each clearly identified GMM. This exclusion applies only when the GMM is
used under conditions of contained use as defined in Article 2(c). It does not apply to the deliberate release of
GMMs. For a GMM to be listed in Part C,

it must be proved that it meets the criteria given below.

2.

GENERAL CRITERIA

2.1.

Strain verification/authentication

Identity of the strain must be precisely established. Modification must be known and verified.

2.2. Documented and established evidence of safety

Documented evidence of the safety of the organism must be provided.

2.3.

Genetic stability

Where any instability could adversely affect safety, evidence of stability is required.

3.

SPECIFIC CRITERIA

3.1.

Non-pathogenic

The GMM should not be capable of causing disease or harm to a healthy human, plant or animal. Since
pathogenicity includes both toxigenicity and allergenicity, the GMM should therefore be:

3.1.1. Non-toxigenic

The GMM should not produce increased toxigenicity as a result of the genetic modification nor be noted for its
toxigenic properties.

3.1.2. Non-allergenic

The GMM should not produce increased allergenicity as a result of the genetic modification nor be a noted
allergen, having, for example, allergenicity comparable in particular with that of the micro-organisms identified in
Council Directive 93/88/EEC of 12 October 1993 amending Directive 90/679/EEC on the protection of workers
from risks related to exposure to biological agents at work (1).

3.2.

No harmful adventitious agents

The GMM should not harbour known harmful adventitious agents such as other micro-organisms, active or latent,
existing alongside or inside the GMM that could cause harm to human health and the environment.

3.3.

Transfer of genetic material

The modified genetic material must not give rise to harm if transferred nor should it be self transmissible or
transferable at a frequency greater than other genes of the recipient or parental micro-organism.

(1) OJ L 268, 29.10.1993, p. 71.

L 73/34

EN

Official Journal of the European Communities

15.3.2001

3.4.

Safety for the environment in the event of a significant and unintended release

GMMs must not produce adverse effects on the environment, immediate or delayed, should any incident involving
a significant and unintended release occur.

GMMs that do not meet the above criteria may not be included in Part C.’